Clinical Trials Browser

Withdrawn × Small Cell Lung Carcinoma × trametinib × Clear all

NCT03266159 2017-12-08

A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors

Phase 2 Withdrawn

Small Cell Lung Carcinoma